首页 | 本学科首页   官方微博 | 高级检索  
     

静脉溶栓治疗急性心肌梗塞并心源性休克分析
引用本文:杜国峰,姚强. 静脉溶栓治疗急性心肌梗塞并心源性休克分析[J]. 医药论坛杂志, 2002, 0(9)
作者姓名:杜国峰  姚强
作者单位:河南省安阳市第二人民医院 安阳455000(杜国峰),安阳县高庄卫生院 安阳县455100(姚强)
摘    要:
目的 评价尿激酶静脉栓对急性心肌梗塞 (AMI)并心源性休克的疗效。方法 笔者对经尿激酶溶栓治疗和未溶栓治疗的AMI并心源笥休克 4周患者的病死率进行了比较。结果 溶栓组 ,尤其溶栓成功组4周病死率显著低于未溶栓组。结论 尿激酶静脉溶栓右有效地降低AMI并心源性休克的病死率。

关 键 词:心肌梗塞  休克  尿激酶  溶栓

Analysis of The Therapeutic Effect of Thrombolysis in AMI Patients Complicated Effect
Du Guofeng et,al. Analysis of The Therapeutic Effect of Thrombolysis in AMI Patients Complicated Effect[J]. Journal of Medical Forum, 2002, 0(9)
Authors:Du Guofeng et  al
Abstract:
Objective For assessint the therapeutic effect of urokinase thrombolysis in AMI patients complicated by cardiogenic shock.Methods We had compared the 4-week moratlity of the patients treated with venous throlbolysis and that of those without thrombolysis.Results Showed that the 4-week mertality of thrombolysis troup, especially successful thrombolysis group,was significantly lower than that of non-thrombolysis group.Conclusion It indicates that urokinase thrombolysis can be dffectively used in treating AMI patients complicated by cardiogenic shock.
Keywords:myocardial infarction  shock  urolinase  thrombolysis
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号